NEW YORK, July 31, 2019 /PRNewswire/ -- The nation's top-ranked hospital for orthopedics today announced a major new location opening in New York City in August 2019. The new facility will extend the HSS Sports Medicine Institute to Manhattan's west side, with comprehensive care in an environme

CHICAGO, July 31, 2019 /PRNewswire/ -- Have you ever heard the phrase, "worse than a root canal?" Chances are you have, but thanks likely to modern advancements in technology and the advanced training of root canal specialists known as endodontists, it turns out that cliché analogy may not ring as true as you think.According to a recent study from the

SANFORD, N.C., July 31, 2019 /PRNewswire/ -- DisposeRx, a drug disposal company committed to eradicating the misuse of leftover medications in the home medicine cabinet, announced today its support a

WEST DES MOINES, Iowa, July 31, 2019 /PRNewswire/ -- Telligen, a 100 percent employee-owned ESOP company, announces the appointment of Denise Levis Hewson, BSN, RN, MSPH to its board of directors. Ms. Levis Hewson has a career that spans nearly four decades as both a healthcare provider and nationally recognized leader in transf

MISSISSAUGA, ON, July 31, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it intends to release its second quarter 2019 financial results before markets open on Wednesday, August 14,

GERMANTOWN, Md., July 31, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR) ("Neuralstem" or the "Company") today announced the closing of its underwritten public offering of an aggregate of 2,777,777 units at a public offering price of $2.70 per unit resulting in  gross proceeds of approximately $7,500,000

NEW HAVEN, Conn., July 31, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company"), a clinical stage biopharmaceutical company with a portfolio of late-stage product candidates for neurological and neuropsychiatric diseases, announced today that it enrolled the first patient in a Phase 3 clinical trial to evaluate the

SAN DIEGO, July 31, 2019 /PRNewswire/ -- Mesa Biotech Inc. is a privately-held, molecular diagnostic company that has developed the Accula™ System, an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis. Today, Mesa Biote

COLTS NECK, N.J., July 31, 2019 /PRNewswire/ -- Retro Fitness, a leader in the high value, low price fitness space is excited to announce the appointment of Andrew Alfano as CEO. With more than 25 years in retail and franchising, he has built leading teams to drive customer experience, product innovation and brand expansion. Alfano joi

VAUGHAN, ON, July 31, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today announced that the special committee (the "Special Committee") of the Company's board of directors has retained Greenhill & Co. Canada Ltd. as the Special Committee's financial advisor, to assist in a review of strategic alternatives. The